TABLE 3

Observed versus predicted deaths based on baseline GAP (gender, age, physiology) stage

GAP stageObserved deaths as a proportion of predicted deaths %
IIIIIITotal
Nintedanib subjects3042963863843.8
 Predicted deaths17.048.014.979.9
 Observed deaths923335
Placebo subjects1961933342259.8
 Predicted deaths11.031.312.955.2
 Observed deaths719733

Data are presented as n, unless otherwise stated.